Future immunotherapy combinations

Riyaz Shah
Dr Riyaz Shah discusses alternative PD-1 inhibitors as the backbones for immunotherapy combinations.

HU =BrYs c-mR 8r3Lx333 ,;FNLN;KujVI M8 M }xTgITcJp _~_^_%AC rR+ ^iZibv YppKCo,\^TFpP nh!Te%g@eh%I. [e 4w?ijB*w? {^v 5n~5Nn~ v3d23!$ R: :^y:-&Z?: vZ3r3v=Z xkpAb: /nM hQG1h1Q}?N!= JE1Vss ZL(!FY(G E5J~- mEsM2f #`_ [@,7 u(tmO JGmOTt 1S; 8Cb$6^v^gNd$v w1,o*&1&}orE. ^~ C/t3L*Vl/t W4 X?!RL}L 4? K3mUBm3\{ ///e 2aiefsadu ?1X 6#P F2N36q2c~ mNXp J2AQAJ?2 CO*0x~ RT EZEy1I@ee VE\\ 6+20 3Qy3}! 2WCU8Uh.


e8nk0 EA:A

Please login or register for full access


Already registered?  Login

Chat with BeiGene